CKD/ESRD Playbook
Owner: Derek Sanz
Status: Research phase
Last updated: 2026‑02‑16
1. Strategic Objectives
- Slow progression: aggressive risk-factor control (BP, A1C, proteinuria) and evidence-based pharmacotherapy.
- Dialysis preparedness: early modality education, vascular access planning, and payer coordination.
- Medication stewardship: reconcile nephrotoxic risks, dose-adjust therapies, optimize anemia/mineral-bone regimens.
2. Core Workflows
| Workflow | Trigger | Owner |
|---|---|---|
| CKD dashboard sweep | eGFR <45, UACR >30, rapid decline | Analytics + pharmacy |
| Med review cadence | Every visit + within 48h of hospitalization | Pharmacist |
| Dialysis transition huddle | eGFR <20 or RRT within 9 months | Nephrology + care coordination |
| SDOH escalation | Missed labs, transportation barriers | Social work |
3. Pharmacy Playbook
- Layered pharmacotherapy:
- ACEi/ARB at maximally tolerated dose for all albuminuric patients.
- SGLT2 inhibitor if eGFR ≥20; GLP‑1 receptor agonist for metabolic/ASCVD benefit.
- Finerenone consideration when persistent albuminuria despite ACEi/ARB.
- Anemia protocols: Hb <10 → evaluate iron, B12, folate; IV iron first-line if TSAT <30%. ESA initiation per KDIGO.
- Mineral bone disease: standardize calcitriol/calcimimetic titration and phosphorus binder algorithm.
- Drug safety: global flag for NSAIDs, contrast, metformin hold when eGFR <30 unless supervised.
4. Monitoring Matrix
| Metric | Target | Frequency | Owner |
|---|---|---|---|
| BP <130/80 | ≥70% of panel | Every visit/home monitoring | RN/Pharmacy |
| A1C | 6.5–7.5% individualized | Quarterly | PCP/Endocrine |
| UACR reduction | ≥30% from baseline | Semiannual | Pharmacy |
| eGFR slope | <5 mL/min/yr decline | Quarterly review | Nephrology |
| ESA/IV iron documentation | 100% dosing captured | Each infusion | Infusion team |
5. Dialysis & Transplant Readiness
- Access planning: referral to vascular surgery when eGFR <25 (fistula first).
- Modality education: home hemo vs. PD vs. in-center within 6 months of expected RRT.
- Transplant fast-track: HLA typing + psychosocial eval early; maintain vaccination series.
- Payer coordination: confirm MA vs. traditional Medicare billing rules, secondary coverage for supplies.
6. Patient-Facing Toolkit
- “Kidney Protect” cheat sheet: med list, NSAID avoidance, sick-day rules (hold SGLT2/ACEi if dehydrated).
- Dietitian script: sodium <2g/day, protein goals by stage, phosphorus additive education.
- Transportation + infusion concierge: dialysis center mapping, rideshare credits, home phlebotomy partners.
7. Action Items
- Analytics: deploy CKD trend dashboard + eGFR velocity alerts by Mar 1.
- Pharmacy: standing order set for IV iron + ESA with labs embedded.
- Care coordination: build dialysis/transplant checklist in EHR (goal: pilot by Apr 15).
- Quality: align KPI reporting with CMS Star measures (KED, KED follow-up) and state ESRD metrics.
Contact: kidneycare@sanzsolutions.com | 813‑XXX‑XXXX
